GBM has also been found to induce WNT5A to mediate tumor cell differentiation into endothelium-like cells via the PAX6/DLX5 transcription program, and subsequently recruit peripheral endothelial cells, which form pseudo-blood vessels, thereby facilitating tumor-invasive growth16. The gene discussed is DLX5; the disease is neoplasm.